
Oriental Aromatics Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- Expected peak revenue of around ₹1200 crore post full capacity utilization of new plants (next few quarters).
- New hydrogenation facility (multi-product) aimed at 700 tons annual capacity, expected to reach 70-80% utilization within 4-5 quarters.
- Mahad single product plant phased for 250 metric tons with a stabilization timeline of 2-3 quarters post-launch.
- Anticipated top line growth from new capacities starting contribution from Q3 FY 2024-25 (Baroda) and second half FY 2024-25 (Mahad).
- Continuous product approvals and phased growth expected; timeline for products moving from marginal to major supplier status is 2-3.5 years.
- India and "China Plus One" strategy considered positive drivers for growth.
- Management cautiously optimistic about volume and revenue growth but refrains from exact percentage guidance currently due to approvals and pricing finalization.
See what Oriental Aromatics management said on margin guidance — free account, 30 seconds.
Fundraise plans
YesSee what Oriental Aromatics management said on order book — free account, 30 seconds.
Capex plans
Yes- The company has completed major CAPEX projects, including the commissioning of a Brownfield hydrogenation plant at Vadodara (commissioned July 2020) and a greenfield project in Mahad, which is in advanced commissioning and expected to contribute from the second half of FY 2024-2025.
- The hydrogenation facility is multi-product, targeting 6-7 products with ~700 tons annual capacity, expected to reach 70-80% utilization within 4-5 quarters.
- Mahad plant is initially a single product plant with ~250 metric tons capacity, aiming for full stabilization 2-3 quarters after going live.
- Incremental depreciation from new facilities expected to be Rs. 8-10 crores annually.
- Peak group-level debt expected at Rs. 280 crores for ongoing expansions.
- Future CAPEX beyond these projects is possible but currently unspecified, with a cautious and conservative approach to funding and debt management.
- The company is optimistic about capturing growth opportunities driven by new capacities and "China Plus One" customer shifts.
Track Oriental Aromatics — get its next earnings analysis in your feed
How does Oriental Aromatics rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Oriental Aromatics rank in Chemicals & Petrochemicals?
Compare Oriental Aromatics against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Oriental Aromatics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…